Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

Conditions: Schizophrenia

Interventions: Drug: Xanomeline/Trospium Chloride; Drug: Placebo

Sponsors: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Not yet recruiting